Australia's most trusted
source of pharma news
Posted 26 November 2025 PM
Moderna ANZ General Manager Michael Azrak has thanked his team and his company for a "once-in-a-lifetime experience" ahead of his departure but is still remaining tight-lipped about his next move.
Azrak took the top job at the height of the COVID-19 pandemic in 2021. Immediately he was faced with the daunting prospect of ensuring reliable supply of mRNA vaccines to allow Australia to re-open while laying the groundwork for the nation's long-term onshore mRNA manufacturing capability.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.